Heimdal Utbytte vs UBS Lux Equity Fund Biotech USD

Heimdal Utbytte vs UBS Lux Equity Fund Biotech USD

1. Heimdal Utbytte

  • Security

    Heimdal Utbytte N

  • Fee

    1.29%

  • ISIN

    NO0012948852

  • Holdings

    25

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 29 holdings in Heimdal Utbytte, where the largest holding is Sparebanken Vest (5.05), followed by Kongsberg (4.8) and DNB (4.8). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in Heimdal Utbytte and UBS Lux Equity Fund Biotech USD.

Heimdal Utbytte UBS Lux Equity Fund Biotech USD
1. Sparebanken Vest
Norway
5.05 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Kongsberg Gruppen ASA
Norway
4.8 %
2. Moderna Inc
9.21 %
3. DNB Bank
Norway
4.8 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. SpareBank 1 SMN
Norway
4.78 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. SpareBank 1 Sør-Norge ASA
Norway
4.75 %
5. AbbVie Inc
USA
4.91 %
6. Protector Forsikring ASA
Norway
4.63 %
6. Gilead Sciences Inc
USA
4.66 %
7. Storebrand
Norway
4.59 %
7. Amgen Inc
USA
4.43 %
8. Equinor ASA
Norway
4.57 %
8. BioNTech SE
4.13 %
9. Aker BP
Norway
4.48 %
9. Karuna Therapeutics Inc
3.75 %
10. Gjensidige Forsikring
Norway
4.44 %
-
11. Orkla Foods AS
Norway
4.41 %
-
12. SpareBank 1 Nord-Norge
Norway
4.22 %
-
13. Mowi
Norway
3.64 %
-
14. Telenor ASA
Norway
3.29 %
-
15. Schibsted A
Norway
3.26 %
-
16. Norconsult ASA
Norway
2.67 %
-
17. Pareto Bank ASA
Norway
2.05 %
-
18. Subsea 7 SA
Norway
1.99 %
-
19. SalMar ASA
Norway
1.74 %
-
20. Atea
1.67 %
-
21. Essity B
Sweden
1.54 %
-
22. Multiconsult ASA
Norway
1.41 %
-
23. Securitas B
Sweden
1.3 %
-
24. Borregaard ASA
Norway
1.29 %
-
25. BW Offshore Ltd
1.28 %
-

The list of fund holdings was last updated on July 25, 2025.